Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this pagefeedback survey


The results below represent 576,025 women who should have had one or more cervical cancer screening tests during the previous 36 months or one cervical cancer screening test and a human papillomavirus test within the last 5 years. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
ThedaCare Physicians
N=35034
87.33 %
View Historical Data
Prevea Health
N=23915
86.29 %
View Historical Data
NOTE: Corrected results displaying effective 7/26/12
Dean Clinic
N=39806
84.30 %
View Historical Data
Gundersen Clinic, Ltd
N=31841
82.31 %
View Historical Data
Aurora Health Care Medical Group
N=119494
82.08 %
View Historical Data
Marshfield Clinic
N=48642
81.16 %
View Historical Data
Aurora UW Medical Group
N=7830
81.14 %
View Historical Data
Bellin Medical Group
N=16778
80.83 %
View Historical Data
ProHealth Care Medical Associates
N=36455
80.58 %
View Historical Data
UW Health Physicians
N=48900
79.81 %
View Historical Data
Monroe Clinic
N=8284
79.74 %
View Historical Data
Mercy Health System
N=32705 n=23727
78.23 %
View Historical Data
Mayo Clinic Health System in Eau Claire
N=20004 n=13584
77.22 %
View Historical Data
Mayo Clinic Health System - Franciscan Healthcare
N=22517 n=17705
77.13 %
View Historical Data
Columbia St. Mary's Community Physicians
N=45440 n=29131
71.41 %
View Historical Data
Wheaton Franciscan Medical Group
N=38380 n=21675
60.53 %
View Historical Data
Aurora Advanced Healthcare

Did Not Report
View Historical Data

There is good evidence that cervical cancer screening significantly reduces the incidence of and mortality from cervical cancer. The US Preventive Services Task Force suggests most of the benefit can be obtained by beginning screening at age 21. Recommendations include screening for women ages 21 through 64 with cytology (Pap smear) at least every 3 years and for women ages 30 through 64 who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years. An individuals specific clinical considerations, risk factors, etc. determine if testing is needed at a more frequent interval. It is recommended that women speak with their health care providers to determine the appropriate interval for their particular situation. There is limited evidence to determine the benefits of continued screening in women older than 65, due to declining incidence of high-grade cervical lesions after middle age. There is fair evidence that screening women older than 65 is associated with an increased risk for potential harm (US Preventive Services Task Force). Therefore, it is also recommended that women over age 65 speak with their health care providers to determine if continued screening is appropriate for their personal medical condition.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.